{rfName}
Az

Indexed in

License and use

Citations

4

Altmetrics

Grant support

This study was supported by the following: The European Research Council (ERC) (ERC-CoG-2020-101001916 (MLLM) ) ; the Spanish Ministry of Economy and Competitiveness (PID2020-113007RB-I00 (MLLM) ) ; and the Center for Networked Biomedical Research on Neurodegenerative Diseases (CIBERNED, Spain (MLLM) ) . The salary of EPMJ was supported by a 2018 Neuroscience Doctoral fellowship from the Fundacion Tatiana Perez de Guzman and an EMBO Scientific Exchange Grant. The salary of Miguel Flor-Garcia was supported by a "Formacion de Personal Investigador" (FPI) contract, associated with the SAF-2017-82185-R grant (MLLM) , supported by the Spanish Ministry of Economy and Competitiveness (PRE2018-085233) . The salary of JTR was supported by a Doctoral fellowship from the Universidad Autonoma de Madrid (FPI-UAM 2017 program) . The salary of HCR was supported by a fellowship from the Fundacion Universitaria San Pablo CEU-Banco Santander (Santander Research Fellowship: Recruitment of young researchers CEU-Santander) . The authors thank J. Molina- Hernandez for help with the analysis of behavioral tests.

Analysis of institutional authors

Terreros-Roncal JAuthorLlorens-Martín MAuthor

Share

January 15, 2024
Publications
>
Article
No

Azithromycin preserves adult hippocampal neurogenesis and behavior in a mouse model of sepsis

Publicated to:BRAIN BEHAVIOR AND IMMUNITY. 117 135-148 - 2024-01-01 117(), DOI: 10.1016/j.bbi.2024.01.005

Authors: Rodríguez-Moreno, CB; Cañeque-Rufo, HE; Flor-García, M; Terreros-Roncal, J; Moreno-Jiménez, EP; Pallas-Bazarra, N; Bressa, C; Larrosa, M; Cafini, F; Llorens-Martín, M

Affiliations

Center for Networked Biomedical Research on Neurodegenerative Diseases (CIBERNED), Madrid, Spain - Author
Center for Networked Biomedical Research on neurodegenerative diseases (CIBERNED), Madrid, Spain. - Author
Center for Networked Biomedical Research on Neurodegenerative Diseases (CIBERNED), Madrid, Spain. Electronic address: m.llorens@csic.es. - Author
Centre for Developmental Neurobiology, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London SE1 1UL, UK - Author
CEU Univ, Univ San Pablo CEU, Ctr Metabol & Bioanal CEMBIO, Dept Chem & Biochem,Sch Pharm,Urbanizacion Montep, Boadilla Del Monte 28660, Spain - Author
CEU Univ, Univ San Pablo CEU, Sch Pharm, Dept Hlth & Pharmaceut Sci, Boadilla Del Monte, Spain - Author
CIBERNED, Ctr Networked Biomed Res Neurodegenerat Dis, Madrid, Spain - Author
Department of Chemistry and Biochemistry, School of Pharmacy, Universidad San Pablo-CEU, CEU Universities, Urbanización Montepríncipe, 28660 Boadilla del Monte, Spain - Author
Department of Food Science and Nutrition, Faculty of Pharmacy, Universidad Complutense de Madrid, 28040 Madrid, Spain. - Author
Department of Health and Pharmaceutical Sciences, School of Pharmacy, Universidad San Pablo-CEU, CEU Universities, Urbanización Montepríncipe, 28660 Boadilla del Monte, Spain. - Author
Department of Molecular Biology, Faculty of Sciences, Universidad Autónoma de Madrid, Madrid, Spain. - Author
Department of Molecular Neuropathology, Centro de Biología Molecular "Severo Ochoa" (CBMSO), Spanish Research Council (CSIC)-Universidad Autónoma de Madrid (UAM), Madrid, Spain - Author
Facultad de Ciencias Experimentales, Universidad Francisco de Vitoria, Ctra. Pozuelo-Majadahonda Km 1,800, 28223, Pozuelo de Alarcón, Madrid. - Author
Faculty of Biomedical and Health Sciences, Universidad Europea de Madrid, Madrid, Spain. Electronic address: fabio.cafini@universidadeuropea.es. - Author
Kings Coll London, Ctr Dev Neurobiol, Inst Psychiat Psychol & Neurosci, London SE1 1UL, England - Author
Kings Coll London, MRC Ctr Neurodev Disorders, London SE1 1UL, England - Author
MRC Centre for Neurodevelopmental Disorders, King's College London, London SE1 1UL, UK. - Author
Univ Autonoma Madrid UAM, Ctr Biol Mol Severo Ochoa CBMSO, Spanish Res Council CSIC, Dept Mol Neuropathol, Madrid, Spain - Author
Univ Autonoma Madrid, Fac Sci, Dept Mol Biol, Madrid, Spain - Author
Univ Complutense Madrid, Fac Pharm, Dept Food Sci & Nutr, Madrid 28040, Spain - Author
Univ Europea Madrid, Fac Biomed & Hlth Sci, Madrid, Spain - Author
Univ Francisco de Vitoria, Fac Ciencias Expt, Ctra Pozuelo Majadahonda Km 1,800, Madrid 28223, Spain - Author
See more

Abstract

The mammalian hippocampus can generate new neurons throughout life. Known as adult hippocampal neurogenesis (AHN), this process participates in learning, memory, mood regulation, and forgetting. The continuous incorporation of new neurons enhances the plasticity of the hippocampus and contributes to the cognitive reserve in aged individuals. However, the integrity of AHN is targeted by numerous pathological conditions, including neurodegenerative diseases and sustained inflammation. In this regard, the latter causes cognitive decline, mood alterations, and multiple AHN impairments. In fact, the systemic administration of Lipopolysaccharide (LPS) from E. coli to mice (a model of sepsis) triggers depression-like behavior, impairs pattern separation, and decreases the survival, maturation, and synaptic integration of adult-born hippocampal dentate granule cells. Here we tested the capacity of the macrolide antibiotic azithromycin to neutralize the deleterious consequences of LPS administration in female C57BL6J mice. This antibiotic exerted potent neuroprotective effects. It reversed the increased immobility time during the Porsolt test, hippocampal secretion of pro-inflammatory cytokines, and AHN impairments. Moreover, azithromycin promoted the synaptic integration of adult-born neurons and functionally remodeled the gut microbiome. Therefore, our data point to azithromycin as a clinically relevant drug with the putative capacity to ameliorate the negative consequences of chronic inflammation by modulating AHN and hippocampal-related behaviors.Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved.

Keywords

azithromycincytokinesdentate gyrusforced swimgut microbiomehuman-brainischemic-strokelong-term azithromycinlpsmaturationmurine modelneural stem-cellsproliferationretrovirusAdult hippocampal neurogenesisAzithromycinCytokinesGut microbiomeLpsNewborn granule neuronsRetrovirus

Quality index

Bibliometric impact. Analysis of the contribution and dissemination channel

The work has been published in the journal BRAIN BEHAVIOR AND IMMUNITY due to its progression and the good impact it has achieved in recent years, according to the agency WoS (JCR), it has become a reference in its field. In the year of publication of the work, 2024 there are still no calculated indicators, but in 2023, it was in position 15/181, thus managing to position itself as a Q1 (Primer Cuartil), in the category Immunology. Notably, the journal is positioned above the 90th percentile.

Impact and social visibility

From the perspective of influence or social adoption, and based on metrics associated with mentions and interactions provided by agencies specializing in calculating the so-called "Alternative or Social Metrics," we can highlight as of 2025-07-04:

  • The use, from an academic perspective evidenced by the Altmetric agency indicator referring to aggregations made by the personal bibliographic manager Mendeley, gives us a total of: 19.
  • The use of this contribution in bookmarks, code forks, additions to favorite lists for recurrent reading, as well as general views, indicates that someone is using the publication as a basis for their current work. This may be a notable indicator of future more formal and academic citations. This claim is supported by the result of the "Capture" indicator, which yields a total of: 35 (PlumX).

With a more dissemination-oriented intent and targeting more general audiences, we can observe other more global scores such as:

  • The Total Score from Altmetric: 4.8.
  • The number of mentions on the social network X (formerly Twitter): 8 (Altmetric).

Leadership analysis of institutional authors

This work has been carried out with international collaboration, specifically with researchers from: United Kingdom.

There is a significant leadership presence as some of the institution’s authors appear as the first or last signer, detailed as follows: First Author (Rodríguez-Moreno CB) and Last Author (LLORENS MARTIN, MARIA VICTORIA).